{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:47:30Z","timestamp":1786373250967,"version":"build-2736575974"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.2215\/cjn.07390713","type":"journal-article","created":{"date-parts":[[2013,12,26]],"date-time":"2013-12-26T21:52:17Z","timestamp":1388094737000},"page":"590-597","source":"Crossref","is-referenced-by-count":8,"title":["Late Kidney Dysfunction in a Kidney Transplant Recipient"],"prefix":"10.2215","volume":"9","author":[{"given":"Michelle A.","family":"Josephson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-24-20230601","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1365-2249.1991.tb02954.x","article-title":"Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection","volume":"86","author":"Feucht","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"R2-24-20230601","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/ki.1993.187","article-title":"Capillary deposition of C4d complement fragment and early renal graft loss","volume":"43","author":"Feucht","year":"1993","journal-title":"Kidney Int"},{"key":"R3-24-20230601","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/MOT.0b013e3283614c5a","article-title":"Renal allograft pathology in the sensitized patient","volume":"18","author":"Cornell","year":"2013","journal-title":"Curr Opin Organ Transplant"},{"key":"R4-24-20230601","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2215\/CJN.01881105","article-title":"Antibody-mediated rejection in renal allografts: Lessons from pathology","volume":"1","author":"Racusen","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R5-24-20230601","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1034\/j.1600-6143.2003.00072.x","article-title":"Antibody-mediated rejection criteria \u2014 an addition to the Banff 97 classification of renal allograft rejection","volume":"3","author":"Racusen","year":"2003","journal-title":"Am J Transplant"},{"key":"R6-24-20230601","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","article-title":"Banff 07 classification of renal allograft pathology: Updates and future directions","volume":"8","author":"Solez","year":"2008","journal-title":"Am J Transplant"},{"key":"R7-24-20230601","doi-asserted-by":"crossref","first-page":"271","DOI":"10.5414\/CNP75271","article-title":"C4d-negative antibody-mediated rejection in renal allografts: Evidence for its existence and effect on graft survival","volume":"75","author":"Haas","year":"2011","journal-title":"Clin Nephrol"},{"key":"R8-24-20230601","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/j.1600-6143.2007.01836.x","article-title":"Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause","volume":"7","author":"Sis","year":"2007","journal-title":"Am J Transplant"},{"key":"R9-24-20230601","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/ki.2011.194","article-title":"Overlapping pathways to transplant glomerulopathy: Chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy","volume":"80","author":"Baid-Agrawal","year":"2011","journal-title":"Kidney Int"},{"key":"R10-24-20230601","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/TP.0b013e31827d62e3","article-title":"Incidence and impact of de novo donor-specific alloantibody in primary renal allografts","volume":"95","author":"Everly","year":"2013","journal-title":"Transplantation"},{"key":"R11-24-20230601","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1111\/j.1600-6143.2009.02800.x","article-title":"De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure","volume":"9","author":"Hidalgo","year":"2009","journal-title":"Am J Transplant"},{"key":"R12-24-20230601","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nrneph.2012.81","article-title":"The impact of donor-specific anti-HLA antibodies on late kidney allograft failure","volume":"8","author":"Loupy","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"R13-24-20230601","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1600-6143.2011.03539.x","article-title":"Solid organ allograft survival improvement in the United States: The long-term does not mirror the dramatic short-term success","volume":"11","author":"Lodhi","year":"2011","journal-title":"Am J Transplant"},{"key":"R14-24-20230601","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1600-6143.2008.02519.x","article-title":"Identifying specific causes of kidney allograft loss","volume":"9","author":"El-Zoghby","year":"2009","journal-title":"Am J Transplant"},{"key":"R15-24-20230601","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-6143.2006.01688.x","article-title":"Banff \u201905 Meeting Report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (\u2018CAN\u2019)","volume":"7","author":"Solez","year":"2007","journal-title":"Am J Transplant"},{"key":"R16-24-20230601","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity","volume":"4","author":"Naesens","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R17-24-20230601","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1111\/j.1600-6143.2011.03718.x","article-title":"Specificity of histological markers of long-term CNI nephrotoxicity in kidney-transplant recipients under low-dose cyclosporine therapy","volume":"11","author":"Snanoudj","year":"2011","journal-title":"Am J Transplant"},{"key":"R18-24-20230601","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM198409133111103","article-title":"Cyclosporine-associated chronic nephropathy","volume":"311","author":"Myers","year":"1984","journal-title":"N Engl J Med"},{"key":"R19-24-20230601","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0140-6736(87)90233-9","article-title":"Cyclosporin conversion versus conventional immunosuppression: Long-term follow-up and histological evaluation","volume":"1","author":"Morris","year":"1987","journal-title":"Lancet"},{"key":"R20-24-20230601","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy","volume":"349","author":"Nankivell","year":"2003","journal-title":"N Engl J Med"},{"key":"R21-24-20230601","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/TP.0b013e31824ad60a","article-title":"Randomized trial comparing late concentration-controlled calcineurin inhibitor or mycophenolate mofetil withdrawal","volume":"93","author":"Mourer","year":"2012","journal-title":"Transplantation"},{"key":"R22-24-20230601","doi-asserted-by":"crossref","first-page":"E151","DOI":"10.1111\/ctr.12076","article-title":"Long-term outcomes after cyclosporine or mycophenolate withdrawal in kidney transplantation \u2014 results from an aborted trial","volume":"27","author":"\u00c5sberg","year":"2013","journal-title":"Clin Transplant"},{"key":"R23-24-20230601","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/TP.0b013e31817fdddb","article-title":"Effect on kidney graft survival of reducing or discontinuing maintenance immunosuppression after the first year posttransplant","volume":"86","author":"Opelz","year":"2008","journal-title":"Transplantation"},{"key":"R24-24-20230601","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1600-6143.2009.02954.x","article-title":"Pathological and clinical characterization of the \u2018troubled transplant\u2019: Data from the DeKAF study","volume":"10","author":"Gourishankar","year":"2010","journal-title":"Am J Transplant"},{"key":"R25-24-20230601","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1111\/j.1600-6143.2010.03240.x","article-title":"Inflammation in areas of tubular atrophy in kidney allograft biopsies: A potent predictor of allograft failure","volume":"10","author":"Mannon","year":"2010","journal-title":"Am J Transplant"},{"key":"R26-24-20230601","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/TP.0b013e3181e065de","article-title":"Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure","volume":"90","author":"Gaston","year":"2010","journal-title":"Transplantation"},{"key":"R27-24-20230601","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1600-6143.2011.03504.x","article-title":"Chronic calcineurin inhibitor nephrotoxicity\u2014lest we forget","volume":"11","author":"Chapman","year":"2011","journal-title":"Am J Transplant"},{"key":"R28-24-20230601","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1600-6143.2011.03505.x","article-title":"Chronic progressive calcineurin nephrotoxicity: An overstated concept","volume":"11","author":"Matas","year":"2011","journal-title":"Am J Transplant"},{"key":"R29-24-20230601","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1111\/j.1600-6143.2011.03719.x","article-title":"Histological characteristics of calcineurin inhibitor toxicity\u2014there is no such thing as specificity!","volume":"11","author":"Mengel","year":"2011","journal-title":"Am J Transplant"},{"key":"R30-24-20230601","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1097\/TP.0b013e31821792fd","article-title":"Chronic renal allograft damage: Existing challenges","volume":"91","author":"Arias","year":"2011","journal-title":"Transplantation"},{"key":"R31-24-20230601","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1681\/ASN.V123574","article-title":"Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries","volume":"12","author":"Mauiyyedi","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R32-24-20230601","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellar\u00e9s","year":"2012","journal-title":"Am J Transplant"},{"key":"R33-24-20230601","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1111\/j.1600-6143.2009.02799.x","article-title":"Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure","volume":"9","author":"Einecke","year":"2009","journal-title":"Am J Transplant"},{"key":"R34-24-20230601","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1111\/j.1600-6143.2009.02761.x","article-title":"Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining","volume":"9","author":"Sis","year":"2009","journal-title":"Am J Transplant"},{"key":"R35-24-20230601","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant"},{"key":"R37-24-20230601","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1111\/ajt.12365","article-title":"Rejection: An integrated response","volume":"13","author":"Nickerson","year":"2013","journal-title":"Am J Transplant"},{"key":"R38-24-20230601","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2215\/CJN.01651105","article-title":"Presensitization: The problem and its management","volume":"1","author":"Jordan","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R39-24-20230601","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1097\/01.ASN.0000145878.92906.9F","article-title":"Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: Report of the NIH IG02 trial","volume":"15","author":"Jordan","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R40-24-20230601","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3233\/HAB-2004-13301","article-title":"In vivo human B-cell subset recovery after in vivo depletion with rituximab, anti-human CD20 monoclonal antibody","volume":"13","author":"Sidner","year":"2004","journal-title":"Hum Antibodies"},{"key":"R41-24-20230601","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-0032-1315622","article-title":"Treatment of late class II antibody-mediated rejection status postkidney transplantation: Two case reports","volume":"21","author":"Siskind","year":"2012","journal-title":"Int J Angiol"},{"key":"R42-24-20230601","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/01.TP.0000060252.57111.AC","article-title":"Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection","volume":"75","author":"Rocha","year":"2003","journal-title":"Transplantation"},{"key":"R43-24-20230601","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1399-3046.2005.00363.x","article-title":"Current approaches to treatment of antibody-mediated rejection","volume":"9","author":"Jordan","year":"2005","journal-title":"Pediatr Transplant"},{"key":"R44-24-20230601","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1744-9987.2009.00664.x","article-title":"Plasmapheresis and intravenous immunoglobulin in early antibody-mediated rejection of the renal allograft: A single-center experience","volume":"13","author":"Slatinska","year":"2009","journal-title":"Ther Apher Dial"},{"key":"R45-24-20230601","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1600-6143.2004.00454.x","article-title":"Rituximab as treatment for refractory kidney transplant rejection","volume":"4","author":"Becker","year":"2004","journal-title":"Am J Transplant"},{"key":"R46-24-20230601","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1600-6143.2009.02591.x","article-title":"Comparison of combination Plasmapheresis\/IVIg\/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection","volume":"9","author":"Lefaucheur","year":"2009","journal-title":"Am J Transplant"},{"key":"R47-24-20230601","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1600-6143.2006.01709.x","article-title":"The utility of splenectomy as rescue treatment for severe acute antibody mediated rejection","volume":"7","author":"Locke","year":"2007","journal-title":"Am J Transplant"},{"key":"R48-24-20230601","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/TP.0b013e31825d1587","article-title":"The treatment of acute antibody-mediated rejection in kidney transplant recipients\u2014a systematic review","volume":"94","author":"Roberts","year":"2012","journal-title":"Transplantation"},{"key":"R49-24-20230601","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/j.transproceed.2012.09.038","article-title":"Eculizumab treatment of acute antibody-mediated rejection in renal transplantation: Case reports","volume":"44","author":"Gonz\u00e1lez-Roncero","year":"2012","journal-title":"Transplant Proc"},{"key":"R50-24-20230601","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.transproceed.2013.02.062","article-title":"Eculizumab for salvage treatment of refractory antibody-mediated rejection in kidney transplant patients: Case reports","volume":"45","author":"Kocak","year":"2013","journal-title":"Transplant Proc"},{"key":"R51-24-20230601","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1016\/j.transproceed.2012.02.037","article-title":"The use of bortezomib as a rescue treatment for acute antibody-mediated rejection: Report of three cases and review of literature","volume":"44","author":"Tzvetanov","year":"2012","journal-title":"Transplant Proc"},{"key":"R52-24-20230601","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1600-6143.2012.04291.x","article-title":"Five-year outcomes in living donor kidney transplants with a positive crossmatch","volume":"13","author":"Bentall","year":"2013","journal-title":"Am J Transplant"},{"key":"R53-24-20230601","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/TP.0b013e3182139da1","article-title":"Inferior kidney allograft outcomes in patients with de novo donor-specific antibodies are due to acute rejection episodes","volume":"91","author":"Cooper","year":"2011","journal-title":"Transplantation"},{"key":"R54-24-20230601","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1600-6143.2009.02577.x","article-title":"Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss","volume":"9","author":"Everly","year":"2009","journal-title":"Am J Transplant"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201403000-00024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:44:00Z","timestamp":1786369440000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201403000-00024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.07390713","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}